少弱精子症中西医融合药物治疗共识

2021-10-30 北京中医药学会男科疾病专家共识组 中国男科学杂志

本共识通过德尔菲法收集问卷方式,结合临床实际、专家经验,梳理中西医融合下少弱精子症的诊疗思路。

中文标题:

少弱精子症中西医融合药物治疗共识

发布日期:

2021-10-30

简要介绍:

男性不育症的治疗有药物治疗、外科治疗(显微)、辅助生殖技术等多种方式, 治疗方案的制定要结合具体病因、患者自身情况等多方面因素进行考量。对于少弱精子症而言,药物治疗是最常用的治疗方式,包括特异性治疗、非特异性治疗(经验性治疗)和中医药治疗。对于有明确病因的患者,采用特异性治疗效果较好;无法明确具体病因或发病机制尚不明确患者可使用非特异性治疗,但疗效有待进一步肯定。在我国,中西医融合治疗少、弱精子症有独特优势。本共识通过德尔菲法收集问卷方式,结合临床实际、专家经验,梳理中西医融合下少弱精子症的诊疗思路。

相关资料下载:
[AttachmentFileName(sort=1, fileName=少弱精子症中西医融合药物治疗共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0f1f11c0022e15af, title=少弱精子症中西医融合药物治疗共识, enTitle=, guiderFrom=中国男科学杂志, authorId=0, author=, summary=本共识通过德尔菲法收集问卷方式,结合临床实际、专家经验,梳理中西医融合下少弱精子症的诊疗思路。, cover=https://img.medsci.cn/20211125/1637833834647_5579292.jpg, journalId=0, articlesId=null, associationId=1967, associationName=北京中医药学会男科疾病专家共识组, associationIntro=北京中医药学会男科疾病专家共识组, copyright=0, guiderPublishedTime=Sat Oct 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">男性不育症的治疗有药物治疗、外科治疗(显微)、辅助生殖技术等多种方式, 治疗方案的制定要结合具体病因、患者自身情况等多方面因素进行考量。对于少弱精子症而言,药物治疗是最常用的治疗方式,包括特异性治疗、非特异性治疗(经验性治疗)和中医药治疗。对于有明确病因的患者,采用特异性治疗效果较好;无法明确具体病因或发病机制尚不明确患者可使用非特异性治疗,但疗效有待进一步肯定。在我国,中西医融合治疗少、弱精子症有独特优势。本共识通过德尔菲法收集问卷方式,结合临床实际、专家经验,梳理中西医融合下少弱精子症的诊疗思路。</span></p>, tagList=[TagDto(tagId=117054, tagName=男科生殖), TagDto(tagId=118496, tagName=少弱精子症)], categoryList=[CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=96208, guiderKeyword=弱精子症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1386, appHits=56, showAppHits=0, pcHits=300, showPcHits=1330, likes=2, shares=7, comments=8, approvalStatus=1, publishedTime=Thu Nov 25 17:54:34 CST 2021, publishedTimeString=2021-10-30, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Nov 25 17:54:23 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 06:31:03 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=少弱精子症中西医融合药物治疗共识.pdf)])
少弱精子症中西医融合药物治疗共识.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1224485, encodeId=6f341224485b9, content=学习,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48802143739, createdName=竭尽全力, createdTime=Sat Jun 04 23:03:44 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191884, encodeId=af09119188483, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220210/fc0df8627f8141ff8e44709fbd350e4c/e92e03d2977547e5bb50b57a546a23b8.jpg, createdBy=1af65715393, createdName=ms3000000493726505, createdTime=Thu Feb 10 16:46:33 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074950, encodeId=88ea10e495069, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Nov 29 06:59:55 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074393, encodeId=5c3910e4393b5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Nov 27 06:57:32 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074044, encodeId=494910e404431, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Nov 26 06:58:23 CST 2021, time=2021-11-26, status=1, ipAttribution=)]
    2022-06-04 竭尽全力

    学习,学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1224485, encodeId=6f341224485b9, content=学习,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48802143739, createdName=竭尽全力, createdTime=Sat Jun 04 23:03:44 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191884, encodeId=af09119188483, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220210/fc0df8627f8141ff8e44709fbd350e4c/e92e03d2977547e5bb50b57a546a23b8.jpg, createdBy=1af65715393, createdName=ms3000000493726505, createdTime=Thu Feb 10 16:46:33 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074950, encodeId=88ea10e495069, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Nov 29 06:59:55 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074393, encodeId=5c3910e4393b5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Nov 27 06:57:32 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074044, encodeId=494910e404431, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Nov 26 06:58:23 CST 2021, time=2021-11-26, status=1, ipAttribution=)]
    2022-02-10 ms3000000493726505

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1224485, encodeId=6f341224485b9, content=学习,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48802143739, createdName=竭尽全力, createdTime=Sat Jun 04 23:03:44 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191884, encodeId=af09119188483, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220210/fc0df8627f8141ff8e44709fbd350e4c/e92e03d2977547e5bb50b57a546a23b8.jpg, createdBy=1af65715393, createdName=ms3000000493726505, createdTime=Thu Feb 10 16:46:33 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074950, encodeId=88ea10e495069, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Nov 29 06:59:55 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074393, encodeId=5c3910e4393b5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Nov 27 06:57:32 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074044, encodeId=494910e404431, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Nov 26 06:58:23 CST 2021, time=2021-11-26, status=1, ipAttribution=)]
    2021-11-29 微探

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1224485, encodeId=6f341224485b9, content=学习,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48802143739, createdName=竭尽全力, createdTime=Sat Jun 04 23:03:44 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191884, encodeId=af09119188483, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220210/fc0df8627f8141ff8e44709fbd350e4c/e92e03d2977547e5bb50b57a546a23b8.jpg, createdBy=1af65715393, createdName=ms3000000493726505, createdTime=Thu Feb 10 16:46:33 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074950, encodeId=88ea10e495069, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Nov 29 06:59:55 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074393, encodeId=5c3910e4393b5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Nov 27 06:57:32 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074044, encodeId=494910e404431, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Nov 26 06:58:23 CST 2021, time=2021-11-26, status=1, ipAttribution=)]
    2021-11-27 微探

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1224485, encodeId=6f341224485b9, content=学习,学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48802143739, createdName=竭尽全力, createdTime=Sat Jun 04 23:03:44 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191884, encodeId=af09119188483, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220210/fc0df8627f8141ff8e44709fbd350e4c/e92e03d2977547e5bb50b57a546a23b8.jpg, createdBy=1af65715393, createdName=ms3000000493726505, createdTime=Thu Feb 10 16:46:33 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074950, encodeId=88ea10e495069, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Mon Nov 29 06:59:55 CST 2021, time=2021-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074393, encodeId=5c3910e4393b5, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Nov 27 06:57:32 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074044, encodeId=494910e404431, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Nov 26 06:58:23 CST 2021, time=2021-11-26, status=1, ipAttribution=)]
    2021-11-26 微探

    学习学习

    0